Join
Live feed
·
PRReleasevia Quantisnow
REGENXBIO Inc. logo

REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting

ByQuantisnow·Wall Street's wire, on your screen.
RGNX· REGENXBIO Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RGNX (REGENXBIO Inc.) and more on Quantisnow.